Teachers Retirement System of the State of Kentucky’s Karyopharm Therapeutics KPTI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-3,098
Closed -$489K 1777
2021
Q1
$489K Hold
3,098
﹤0.01% 1301
2020
Q4
$719K Buy
3,098
+1,371
+79% +$318K 0.01% 1008
2020
Q3
$378K Hold
1,727
﹤0.01% 1203
2020
Q2
$491K Hold
1,727
0.01% 1074
2020
Q1
$498K Buy
1,727
+480
+38% +$132K 0.01% 976
2019
Q4
$358K Hold
1,247
﹤0.01% 1327
2019
Q3
$180K Hold
1,247
﹤0.01% 1538
2019
Q2
$112K Hold
1,247
﹤0.01% 1638
2019
Q1
$109K Hold
1,247
﹤0.01% 1654
2018
Q4
$175K Hold
1,247
﹤0.01% 1558
2018
Q3
$318K Hold
1,247
﹤0.01% 1463
2018
Q2
$318K Buy
+1,247
New +$308K ﹤0.01% 1471

Other funds holding KPTI

Teachers Retirement System of the State of Kentucky's KPTI Position: Q2 2021 in Review

Teachers Retirement System of the State of Kentucky sold out of Karyopharm Therapeutics (KPTI) in Q2 2021, closing a stake of 3,098 shares — an estimated $489K sold.

Teachers Retirement System of the State of Kentucky first reported a position in KPTI in Q2 2018 and held it in 12 quarters. The position peaked at $719K in Q4 2020. 153 funds tracked by Wall St. Rank hold KPTI as of Q2 2021.

  • Teachers Retirement System of the State of Kentucky reported no remaining Karyopharm Therapeutics position as of Q2 2021 after selling out during the quarter.
  • Teachers Retirement System of the State of Kentucky sold 3,098 Karyopharm Therapeutics shares in Q2 2021, an estimated $489K.
  • Teachers Retirement System of the State of Kentucky first reported a position in Karyopharm Therapeutics in Q2 2018 and held it in 12 quarters.
  • Teachers Retirement System of the State of Kentucky's Karyopharm Therapeutics position peaked at $719K in Q4 2020.
  • 153 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2021.

Based on Teachers Retirement System of the State of Kentucky's 13F filing for Q2 2021, filed 28 Jul 2021.